“…33 One of the biggest concerns about serotype replacement has been regarding pneumococcal disease, where the emergence of non-7-valent (non-PCV7) pneumococcal vaccine serotypes (1, 3, 7F, 15B/C/F, 10A, 19A, 22F, 33F, and 38) could offset vaccineinduced herd protection. 1,25,35,37,45,[77][78][79][80][81][82][83] The 10-and 13-valent pneumococcal vaccines might allow less replacement disease due to a reduced incidence of all PCV7 serotypes plus several additional serotypes (PCV6C). 79,81,82,84,85 Furthermore, increases in Figure 3.…”